Gabather (abbreviated form of GABA Therapeutics) focuses on the development of highly potent and selective GABAA receptor modulators targeting the principal inhibitory neurotransmitter in the mammalian brain, gamma aminobutyric acid (GABA). Our drug development candidates are small molecular weight compounds designed through proprietary pharmacophore modelling. Our development pipeline includes candidates targeting the GABAA receptor in both preclinical and clinical development and we aim to produce novel pharmaceuticals such as antipsychotics, antidepressants, anxiolytics, analgesics and cognitive enhancers to treat CNS diseases with high unmet need.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Forskargatan 20 J, Södertälje,stockholm County 151 36,sweden
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.gabather.com/
- Keywords
- Pharmaceuticals, Central Nervous System (CNS), Drug Discovery, Drug Development, GABAA receptor modulators, Affective disorders, Cognition, Clinical trials, Phase 1, Phase 2, Schizophrenia, Mild Cognitive Impairment, Antidepressants.
- HQ
- Södertälje, Stockholm County
Gabather Questions
Gabather's website is http://www.gabather.com/
Gabather's LinkedIn profile is https://se.linkedin.com/company/gabather
Gabather has
6 employees.
View email and phone details for 6
employees at Gabather.
Gabather's industry is
Pharmaceutical Manufacturing
Gabather's top competitors are
Takura Ab,
Diagonal Bio,
Presscise Ab,
Follicum,
Hansa Biopharma,
Mindig,
Industrial Biotechnology Cluster Finland,
Alésia Consulting,
Addex Pharmaceuticals Ltd,
2a Pharma.
Gabather's categories are Pharmaceutical Manufacturing
Gabather's founding year is 2014
